Xurance Trademark Details
Word Mark | Xurance |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Eli Lilly and Company of Indianapolis, IN
View all trademarks for Eli Lilly and CompanySerial Number | 77511184 |
---|---|
Status Date | Monday, September 19, 2011 |
Filing Date | Monday, September 19, 2011 |
Attorney | Bruce W. Longbottom |
Correspondent
BRUCE W. LONGBOTTOM
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285-0001
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285-0001
Case File Statements
Goods & Services | Pharmaceutical and medicinal preparations, namely, for the treatment of cardiovascular diseases and disorders, pulmonary arterial hypertension, and urological systems |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, July 3, 2008 |
Primary Code | 005 |
Trademark Timeline
-
Jun 30 2008Trademark application filed with USPTO
-
Jul 03 2008New Application Entered In Tram
-
Oct 03 2008Assigned To Examiner
-
Oct 06 2008Approved For Pub - Principal Register
-
Oct 20 2008Law Office Publication Review Completed
-
Oct 20 2008Assigned To Lie
-
Nov 05 2008Notice of Publication
-
Nov 25 2008Published For Opposition
-
Feb 17 2009Noa Mailed - Sou Required From Applicant
-
Aug 03 2009Extension 1 Filed
-
Aug 03 2009Teas Extension Received
-
Aug 31 2009Extension 1 Granted
-
Aug 31 2009Case Assigned To Intent To Use Paralegal
-
Feb 11 2010Extension 2 Filed
-
Feb 11 2010Teas Extension Received
-
Mar 02 2010Extension 2 Granted
-
Jul 06 2010Extension 3 Filed
-
Jul 06 2010Teas Extension Received
-
Jul 08 2010Extension 3 Granted
-
Jul 09 2010Notice of Approval of Extension Request E-Mailed
-
Feb 16 2011Extension 4 Filed
-
Feb 16 2011Teas Extension Received
-
Feb 22 2011Extension 4 Granted
-
Feb 23 2011Notice of Approval of Extension Request E-Mailed
-
Sep 19 2011Abandonment Notice Mailed - No Use Statement Filed
-
Sep 19 2011Abandonment - No Use Statement Filed